胃癌患者化疗后生活质量的影响因素及个体化营养干预影响

doi:10.16689/j.cnki.cn11-9349/r.2020.02.018

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (431 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探究胃癌患者化疗后生活质量的影响因素及个体化营养干预的作用。方法选取2017年1月至2019年1月于首都医科大学附属北京康复医院就诊的患者100例，按照营养干预方式的不同，分为观察组与对照组，每组50例，观察组患者采取个体化营养干预，对照组采取常规营养干预。比较化疗前后两组患者体质指数（BMI）、营养指数、外周血指标变化，两组患者并发症发生概率及生活质量评分比较，并利用多因素Logistic回归分析影响胃癌患者化疗后生活质量的因素。结果观察组患者经个体化营养干预后BMI、营养指数（PNI）、前白蛋白（PALB）、血清白蛋白（ALB）及转铁蛋白（TRF）明显高于对照组，并且两组患者经营养干预后，与化疗前比较BMI呈现升高的趋势，INQ、PALB、ALB及TRF等均呈现降低的趋势，差异具有统计学意义（P<0.05）；观察组患者出现并发症的概率明显低于对照组（χ2=4.336，P=0.037）；化疗后两组患者5个功能领域、总体健康状态评分明显升高，且观察组患者升高比对照组明显，而3个症状领域评分则呈现降低的趋势（P<0.05）；Logistic回归分析发现发生淋巴结转移、家庭月收入≤5000元、合并器官切除、居住地为农村及营养不良是影响胃癌患者化疗后生活质量的主要因素。结论淋巴结转移、工作情况、合并器官切除、手术范围及营养状况对胃癌患者化疗后生活质量有重要影响，个体化营养干预能够促进胃癌患者化疗后身体指标改善，有利于提高患者的生存质量。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	张文荣
	韩莹
	邓海连
	张丽娟

关键词 ：胃癌, 化疗, 生活质量, 影响因素, 个体化营养治疗

Abstract：Objective To investigate the influencing factors of quality of life and individualized nutritional intervention in patients with gastric cancer after chemotherapy. Methods From January 2017 to January 2019， 100 patients admitted to Beijing Rehabilitation Hospital Affiliated to Capital Medical University were divided into the observation group （n=50） and the control group （n=50） given different nutritional intervention. The patients in the observation group were treated with individualized nutrition intervention， while the control group was treated with routine nutrition intervention. The changes of body mass index， nutrition index and peripheral blood index， the probability of complications and the score of quality of life in the two groups were compared before and after chemotherapy， and the factors affecting the quality of life of patients with gastric cancer after chemotherapy were analyzed by multivariate Logistic regression analysis. Results The body mass index （BMI）， nutrition index （PNI）， prealbumin （PALB）， serum albumin （ALB） and transferrin （TRF） were significantly higher in the observation group than those in the control group. After nutritional intervention， BMI and TRF in the two groups showed an upward trend compared with those before chemotherapy， and the difference was statistically significant（P<0.05）. The probability of complications was significantly lower in the observation group than in the control group.（ χ2=4.336，P=0.037）. After chemotherapy， the scores of overall health status in the two groups were significantly higher than those in the control group， while the scores in the three symptom areas in the observation group were significantly higher than those in the control group（P<0.05）. Logistic regression analysis found that lymph node metastasis， monthly household income ≤5000 yuan， combined organ resection， rural residence and malnutrition were the main factors affecting the quality of life of gastric cancer patients after chemotherapy. Conclusion Lymph node metastasis， working condition， combined organ resection， surgical scope and nutritional status have important effects on the quality of life of patients with gastric cancer after chemotherapy. Individualized nutrition intervention can promote the improvement of physical indexes of patients with gastric cancer after chemotherapy， which is beneficial to improve the quality of life of patients with gastric cancer.

Key words： Gastric cancer Chemotherapy Quality of life Influencing factors Individualized nutritional intervention

基金资助:2018年首都卫生发展科研专项（京卫科研 2043 号）

通讯作者: 张文荣，电子邮箱：q46uvq@163.com

引用本文:

张文荣，韩莹，邓海连，张丽娟. 胃癌患者化疗后生活质量的影响因素及个体化营养干预影响[J]. 肿瘤代谢与营养电子杂志, 2020, 7(2): 231-235.
Zhang Wenrong， Han Ying， Deng Hailian， Zhang Lijuan. Study on the intervention of individualized nutrition therapy in patients with postoperative chemotherapy of gastric cancer and the analysis of factors affecting their quality of life. Electron J Metab Nutr Cancer, 2020, 7(2): 231-235.

1.WEI J C，LIANG Y，QIANG K，et al. The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer［J］. Sci Rep， 2017， 7（2）: 43536-43541.
2.北京市科委重大项目《早期胃癌治疗规范研究》专家组，柴宁莉，翟亚奇，等. 早期胃癌内镜下规范化切除的专家共识意见（2018，北京）［J］. 中华胃肠内镜电子杂志， 2018， 5（2）: 49-60.
3.陈海云. 两种不同吻合方式预防近端胃切除术后反流性食道炎的效果比较［J］. 中国药物与临床， 2017， 17（4）: 571-573.
4.LI T，MENG X L. Curative effect of digestive tract reconstruction after radical gastrectomy for distal gastric cancer［J］. J Laparoendosc Adv Surg Tech A， 2018， 28（11）: 1294-1297.
5.ZONG L， LI H， LI S. Effects of neoadjuvant chemotherapy combined with enteral nutrition on perioperative immunity， inflammation and intestinal flora in gastric cancer patients［J］. J BUON， 2019， 24（3）: 1113-1119.
6.VERSTEEG K S， KONINGS I R， LAGAAY A M， et al. Prediction of treatment-related toxicity and outcome with geriatric assessment in elderly patients with solid malignancies treated with chemotherapy: a systematic review［J］. Ann Oncol， 2014， 25（10）: 1914-1918.
7.刘慧光. 个性化营养管理在消化系统恶性肿瘤患者中的应用［J］. 中华现代护理杂志， 2018， 24（22）: 2681-2685.
8.中华人民共和国卫生部通告［J］. 中国卫生法制， 2010， 2（4）: 8-8.
9.邱卫清，蒋俊燕. 个体化营养干预对胃癌根治术后患者的作用［J］. 全科医学临床与教育， 2015， 1（4）: 451-453.
10.SUN X， WANG G， LIU C， et al. Comparison of short-term outcomes following minimally invasive versus open Sweet esophagectomy for Siewert type II adenocarcinoma of the esophagogastric junction［J］. Thorac Cancer， 2020.
11.HUANG L， WEI Y， SHEN S， et al. Therapeutic effect of apatinib on overall survival is mediated by prolonged progression-free survival in advanced gastric cancer patients［J］. Oncotarget， 2017， 8（17）: 29346-29354.
12.MARKAR S R， MACKENZIE H， MIKHAIL S， et al. Surgical resection of hepatic metastases from gastric cancer: outcomes from national series in England［J］. Gastric Cancer， 2017， 20（2）: 1-8.
13.KAITO A， KINOSHITA T， SHITARA K， et al. Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery［J］. Eur J Surg Oncol， 2017， 43（4）: 801-807.
14.WANG QW， ZHANG XT， LU M， et al. Impact of duration of adjuvant chemotherapy in radically resected patients with T4bN1-3M0/TxN3bM0 gastric cancer［J］. World J Gastrointest Oncol， 2018， 10（1）: 31-39.
15.KONG S H， LEE H J， NA J R， et al. Effect of perioperative oral nutritional supplementation in malnourished patients who undergo gastrectomy: A prospective randomized trial［J］. Surgery， 2018， 164（6）: 1263-1270.
16.DONG W， LIU X， ZHU S， et al. Selection and optimization of nutritional risk screening tools for esophageal cancer patients in China［J］. Nutr Res Pract， 2020， 14（1）: 20-24.
17.CANO-TORRES E A， SIMENTAL-MENDA L E， MORALES-GARZA L A， et al. Impact of nutritional intervention on length of hospital stay and mortality among hospitalized patients with malnutrition: A clinical randomized controlled trial［J］. J Am Coll Nutr， 2017， 36（4）: 235-239.
18.李雪娇，黄迎春，刘思彤，等. 营养不良患者人体成分及能量代谢特点分析［J］. 现代仪器与医疗， 2017， 23（1）: 123-125.
19.SEILER W O， STHELIN H B. Decubitus ulcers: treatment through five therapeutic principles［J］. Geriatrics， 1985， 40（9）: 30-44.
20.刘慧琳，张丹，邓祥竹，等. 血清白蛋白、前白蛋白、视黄醇结合蛋白及转铁蛋白在胃癌术后肠外营养支持中的意义［J］. 中国医药导报， 2018， 15（5）: 113-116.
21.LV Y， HAN X， XU X F， et al. Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection［J］. BMC Cancer， 2019， 19（1）: 335.
22.COIMBRA F J F， DE JESUS VHF， RIBEIRO HSC， et al. Impact of ypT， ypN， and adjuvant therapy on survival in gastric cancer patients treated with perioperative chemotherapy and radical surgery［J］. Ann Surg Oncol， 2019， 26（11）: 3618-3626.
23.KNIGHT W R C， ZYLSTRA J， VAN HEMELRIJCK M，et al. Patterns of recurrence in oesophageal cancer following oesophagectomy in the era of neoadjuvant chemotherapy［J］. BJS Open， 2018， 1（6）: 182-190.
24.王聪，王丹丹. 延续性护理干预对全胃切除术后患者健康状况及生活质量的影响［J］. 现代中西医结合杂志， 2017， 26（3）: 333-335.